Insulin-Like growth factor-i receptor blockade improves outcome in mouse model of lung injury

Jung Eun Choi, Sung Soon Lee, Donald A. Sunde, Isham Huizar, Kathy L. Haugk, Victor J. Thannickal, Ragini Vittal, Stephen R. Plymate, Lynn M. Schnapp

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Rationale: The insulin-like growth factor-I (IGF-I) pathway is an important determinant of survival and proliferation in many cells. However, little is known about the role of the IGF-I pathway in lung injury. We previously showed elevated levels of IGF-I in bronchoal- veolar lavage fluid from patients with acute respiratory distress syndrome. Furthermore, immunodepletion of IGF from acute respiratory distress syndrome bronchoalveolar lavage increased fibro- blast apoptosis. Objectives: We examined the effect of blockade of type 1 IGF tyrosine kinase receptor (IGF-IR) in a murine model of bleomycin-induced lung injury and fibrosis. Methods-: Mice were treated with a monoclonal antibody against the IGF-I receptor (A12) or vehicle after intratracheal bleomycin instillation. Measurements and Main Results: Mice treated with A12 antibody had significantly improved survival after bleomycin injury compared with control mice. Both groups of mice had a similar degree of fibrosis on days 7 and 14, but by Day 28 the A12-treated group had significantly less fibrosis. Delayed treatment with A12 also resulted in decreased fibrosis. A12-treated mice had significantly decreased apoptotic cells on Day 28 compared with control mice. We confirmed that A12 treatment induced mouse lung fibroblast apoptosis in vitro. In addition, IGF-I increased lung fibroblast migration. The primary pathway activated by IGF-I in lung fibroblasts was the insulin receptor substrate-2/phosphatidylinositol 3-kinase/Akt axis. Conclusions: IGF-I regulated survival and migration of fibrogenic cells in the lung. Blockade of the IGF pathway increased fibroblast apoptosis and subsequent resolution of pulmonary fibrosis. Thus, IGF-IR may be a potential target for treatment of lung injury and fibrosis.

Original languageEnglish (US)
Pages (from-to)212-219
Number of pages8
JournalAmerican journal of respiratory and critical care medicine
Volume179
Issue number3
DOIs
StatePublished - Feb 1 2009

Fingerprint

Somatomedin Receptors
Lung Injury
compound A 12
Insulin-Like Growth Factor I
Fibrosis
Bleomycin
Fibroblasts
Lung
Adult Respiratory Distress Syndrome
Apoptosis
Survival
Phosphatidylinositol 3-Kinase
Insulin Receptor Substrate Proteins
IGF Type 1 Receptor
Pulmonary Fibrosis
Bronchoalveolar Lavage Fluid
Receptor Protein-Tyrosine Kinases
Bronchoalveolar Lavage
Cell Movement
Therapeutics

Keywords

  • Insulin-like growth factor
  • Lung fibrosis
  • Lung injury

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Choi, J. E., Lee, S. S., Sunde, D. A., Huizar, I., Haugk, K. L., Thannickal, V. J., ... Schnapp, L. M. (2009). Insulin-Like growth factor-i receptor blockade improves outcome in mouse model of lung injury. American journal of respiratory and critical care medicine, 179(3), 212-219. https://doi.org/10.1164/rccm.200802-228OC

Insulin-Like growth factor-i receptor blockade improves outcome in mouse model of lung injury. / Choi, Jung Eun; Lee, Sung Soon; Sunde, Donald A.; Huizar, Isham; Haugk, Kathy L.; Thannickal, Victor J.; Vittal, Ragini; Plymate, Stephen R.; Schnapp, Lynn M.

In: American journal of respiratory and critical care medicine, Vol. 179, No. 3, 01.02.2009, p. 212-219.

Research output: Contribution to journalArticle

Choi, JE, Lee, SS, Sunde, DA, Huizar, I, Haugk, KL, Thannickal, VJ, Vittal, R, Plymate, SR & Schnapp, LM 2009, 'Insulin-Like growth factor-i receptor blockade improves outcome in mouse model of lung injury', American journal of respiratory and critical care medicine, vol. 179, no. 3, pp. 212-219. https://doi.org/10.1164/rccm.200802-228OC
Choi, Jung Eun ; Lee, Sung Soon ; Sunde, Donald A. ; Huizar, Isham ; Haugk, Kathy L. ; Thannickal, Victor J. ; Vittal, Ragini ; Plymate, Stephen R. ; Schnapp, Lynn M. / Insulin-Like growth factor-i receptor blockade improves outcome in mouse model of lung injury. In: American journal of respiratory and critical care medicine. 2009 ; Vol. 179, No. 3. pp. 212-219.
@article{2cd1adcf1e4444069aa289d70199e22e,
title = "Insulin-Like growth factor-i receptor blockade improves outcome in mouse model of lung injury",
abstract = "Rationale: The insulin-like growth factor-I (IGF-I) pathway is an important determinant of survival and proliferation in many cells. However, little is known about the role of the IGF-I pathway in lung injury. We previously showed elevated levels of IGF-I in bronchoal- veolar lavage fluid from patients with acute respiratory distress syndrome. Furthermore, immunodepletion of IGF from acute respiratory distress syndrome bronchoalveolar lavage increased fibro- blast apoptosis. Objectives: We examined the effect of blockade of type 1 IGF tyrosine kinase receptor (IGF-IR) in a murine model of bleomycin-induced lung injury and fibrosis. Methods-: Mice were treated with a monoclonal antibody against the IGF-I receptor (A12) or vehicle after intratracheal bleomycin instillation. Measurements and Main Results: Mice treated with A12 antibody had significantly improved survival after bleomycin injury compared with control mice. Both groups of mice had a similar degree of fibrosis on days 7 and 14, but by Day 28 the A12-treated group had significantly less fibrosis. Delayed treatment with A12 also resulted in decreased fibrosis. A12-treated mice had significantly decreased apoptotic cells on Day 28 compared with control mice. We confirmed that A12 treatment induced mouse lung fibroblast apoptosis in vitro. In addition, IGF-I increased lung fibroblast migration. The primary pathway activated by IGF-I in lung fibroblasts was the insulin receptor substrate-2/phosphatidylinositol 3-kinase/Akt axis. Conclusions: IGF-I regulated survival and migration of fibrogenic cells in the lung. Blockade of the IGF pathway increased fibroblast apoptosis and subsequent resolution of pulmonary fibrosis. Thus, IGF-IR may be a potential target for treatment of lung injury and fibrosis.",
keywords = "Insulin-like growth factor, Lung fibrosis, Lung injury",
author = "Choi, {Jung Eun} and Lee, {Sung Soon} and Sunde, {Donald A.} and Isham Huizar and Haugk, {Kathy L.} and Thannickal, {Victor J.} and Ragini Vittal and Plymate, {Stephen R.} and Schnapp, {Lynn M.}",
year = "2009",
month = "2",
day = "1",
doi = "10.1164/rccm.200802-228OC",
language = "English (US)",
volume = "179",
pages = "212--219",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "3",

}

TY - JOUR

T1 - Insulin-Like growth factor-i receptor blockade improves outcome in mouse model of lung injury

AU - Choi, Jung Eun

AU - Lee, Sung Soon

AU - Sunde, Donald A.

AU - Huizar, Isham

AU - Haugk, Kathy L.

AU - Thannickal, Victor J.

AU - Vittal, Ragini

AU - Plymate, Stephen R.

AU - Schnapp, Lynn M.

PY - 2009/2/1

Y1 - 2009/2/1

N2 - Rationale: The insulin-like growth factor-I (IGF-I) pathway is an important determinant of survival and proliferation in many cells. However, little is known about the role of the IGF-I pathway in lung injury. We previously showed elevated levels of IGF-I in bronchoal- veolar lavage fluid from patients with acute respiratory distress syndrome. Furthermore, immunodepletion of IGF from acute respiratory distress syndrome bronchoalveolar lavage increased fibro- blast apoptosis. Objectives: We examined the effect of blockade of type 1 IGF tyrosine kinase receptor (IGF-IR) in a murine model of bleomycin-induced lung injury and fibrosis. Methods-: Mice were treated with a monoclonal antibody against the IGF-I receptor (A12) or vehicle after intratracheal bleomycin instillation. Measurements and Main Results: Mice treated with A12 antibody had significantly improved survival after bleomycin injury compared with control mice. Both groups of mice had a similar degree of fibrosis on days 7 and 14, but by Day 28 the A12-treated group had significantly less fibrosis. Delayed treatment with A12 also resulted in decreased fibrosis. A12-treated mice had significantly decreased apoptotic cells on Day 28 compared with control mice. We confirmed that A12 treatment induced mouse lung fibroblast apoptosis in vitro. In addition, IGF-I increased lung fibroblast migration. The primary pathway activated by IGF-I in lung fibroblasts was the insulin receptor substrate-2/phosphatidylinositol 3-kinase/Akt axis. Conclusions: IGF-I regulated survival and migration of fibrogenic cells in the lung. Blockade of the IGF pathway increased fibroblast apoptosis and subsequent resolution of pulmonary fibrosis. Thus, IGF-IR may be a potential target for treatment of lung injury and fibrosis.

AB - Rationale: The insulin-like growth factor-I (IGF-I) pathway is an important determinant of survival and proliferation in many cells. However, little is known about the role of the IGF-I pathway in lung injury. We previously showed elevated levels of IGF-I in bronchoal- veolar lavage fluid from patients with acute respiratory distress syndrome. Furthermore, immunodepletion of IGF from acute respiratory distress syndrome bronchoalveolar lavage increased fibro- blast apoptosis. Objectives: We examined the effect of blockade of type 1 IGF tyrosine kinase receptor (IGF-IR) in a murine model of bleomycin-induced lung injury and fibrosis. Methods-: Mice were treated with a monoclonal antibody against the IGF-I receptor (A12) or vehicle after intratracheal bleomycin instillation. Measurements and Main Results: Mice treated with A12 antibody had significantly improved survival after bleomycin injury compared with control mice. Both groups of mice had a similar degree of fibrosis on days 7 and 14, but by Day 28 the A12-treated group had significantly less fibrosis. Delayed treatment with A12 also resulted in decreased fibrosis. A12-treated mice had significantly decreased apoptotic cells on Day 28 compared with control mice. We confirmed that A12 treatment induced mouse lung fibroblast apoptosis in vitro. In addition, IGF-I increased lung fibroblast migration. The primary pathway activated by IGF-I in lung fibroblasts was the insulin receptor substrate-2/phosphatidylinositol 3-kinase/Akt axis. Conclusions: IGF-I regulated survival and migration of fibrogenic cells in the lung. Blockade of the IGF pathway increased fibroblast apoptosis and subsequent resolution of pulmonary fibrosis. Thus, IGF-IR may be a potential target for treatment of lung injury and fibrosis.

KW - Insulin-like growth factor

KW - Lung fibrosis

KW - Lung injury

UR - http://www.scopus.com/inward/record.url?scp=61449109155&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61449109155&partnerID=8YFLogxK

U2 - 10.1164/rccm.200802-228OC

DO - 10.1164/rccm.200802-228OC

M3 - Article

C2 - 19011156

AN - SCOPUS:61449109155

VL - 179

SP - 212

EP - 219

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 3

ER -